Approval · Notice of Compliance 1378 · 2000
TALWIN: Notice of Compliance 1378
Issued November 2, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1378
- Date
- November 2, 2000
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Narcotic analgesic
Products in this notice
Medicinal ingredients
- PENTAZOCINE HCL 50 MG per TAB
- PENTAZOCINE LACTATE 30 MG per ML